shadow_tr

Research


Previous Studies

» ACCORD

» Katrina

» TINSAL-T2D

» Libra

» Basal Plus

» Zemplar

» Kaiser

 


ACCORD: Action to Control Cardiovascular Risk in Diabetes.

  • Sponsor: NIH
  • Principal Investigator: Dr. Fonseca
  • Study dates: 2001-2009

Katrina: Katrina Impact on Diabetes

  • Sponsor: American Heart Association
  • Principal Investigator: Dr. Fonseca
  • Study dates: 2006-2009

TINSAL-T2D: Targeting Inflammation Using Salsalate for Type 2 Diabetes.

  • Sponsor: NIH
  • Principal Investigator: Dr. Fonseca
  • Collaboration: Joslin Diabetes Clinic
  • Study dates: 2006-2011

Basal Plus Trial: Basal Bolus versus Basal Insulin Regimen for the Treatment of Hospitalized Patients with Type 2 Diabetes Mellitus: A Randomized, Open Labeled, Non-Inferiority Controlled Study.

  • Sponsor: Sanofi-Aventis
  • Principal investigator: Dr. Khan.
  • Collabortion: Emory University
  • Study dates: 2010-2011

Zemplar: Effect of Paricalcitol (Zemplar) on Endothelial Function and Inflammation in Type 2 Diabetes and Chronic Kidney Disease

  • Sponsor: Abbott Laboratories
  • Principal investigator: Dr. Fonseca.
  • Collabortion: Scott & White Clinic
  • Study dates: 2010-2012

Libra: The Effect of Detemir and Aspart Insulin on Intimal Hyperplasia Following Ballon Catheter Injury in Insulin Resistance and Early Diabetes (Zucker Fatty Rats).

  • Sponsor: Novo Nordisk
  • Principal Investigator: Dr. Fonseca
  • Study dates: 2010-2012

Kaiser: Sub-Study of TINSAL-T2D Salsalate: A Diabetes Treatment for Carbonyl, Oxidative & Nitrosative Stress.

  • Sponsor: NIH & Kaiser Foundation Research Institute.
  • Co-Investigator: Dr. Fonseca
  • Collaboration: Dr. Barzilay
  • Study dates: 2010-2012

 

1430 Tulane Ave, New Orleans, LA 70112 504-988-5263 medsch@tulane.edu